Indicated in kidney troubles with pain in the back, extending to different parts, sometimes difficult to locate; the pain is stitching, jerking, lancinating, tearing. Also in diseases of the liver, with indigestion, vomiting of food, soreness of the liver, bilious colic, gall-stone colic, and jaundice. In lumbago, the pain extending from the back around the body and down the legs with bright-red urine containing mucous sediment.
Although fibromyalgia is a real neurological condition, it is not uncommon for FM suffers to be treated as if “it’s all in your head.” Support, understanding and even basic information can be hard to come by for those coping with the intense pain and fatigue of this debilitating chronic illness, as well as the grief, anger and isolation that often accompany it’s onset.
A comprehensive guide to the diagnosis and treatment of chronic fatigue syndrome and fibromyalgia vital help for the millions of people suffering from pain, fatigue, and sleep problems.
The original edition of this classic survival manual offered the first comprehensive patient guide for managing these conditions. Its extensive set of healing tools included targeted bodywork for painful trigger points and strategies to helpccope with chronic pain and sleep problems and the numbing effects of fibrofog.
Fibromyalgia is a misunderstood, misdiagnosed disease whose symptoms include severe muscle pain, fatigue, sleep problems, and depression. The sufferers, mostly middle-aged women, don’t get much respect, and in the past, patients were often told the disease was in their heads.
Results from the largest study of chronic fatigue syndrome to date suggests that there are specific genes and gene activity patterns that make some people more prone to develop the disorder.
The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery (unresectable SCCHN). This is the first drug approved for head and neck cancer that has shown a survival benefit in this population. Erbitux was also approved today for use alone (monotherapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.
The Food and Drug Administration approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression.
In numerous studies over the years, participants with inflammatory diseases have reported less joint stiffness, swelling, tenderness, and overall fatigue when taking omega-3s.
Points to remember practicing moderation when using hand-held electronics: